Schedule 13G ownership disclosure

ZIOPHARM ONCOLOGY INC

Security class unavailable · CUSIP: 98973P101

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
13,085,758
Percent of class
7.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-008766
Form type
SC 13G/A
Filer
WHITE ROCK CAPITAL MANAGEMENT LP
CIK
CIK 1051272
Filed
Jan 30, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub